COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 2 of 5 for:    Eyenovia [Lead]

Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation (MIST-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03751631
Recruitment Status : Completed
First Posted : November 23, 2018
Last Update Posted : February 21, 2020
Information provided by (Responsible Party):
Eyenovia Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 11, 2019
Actual Study Completion Date : January 11, 2019
Certification/Extension First Submitted : January 31, 2020